title: Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.
authors.affiliation: Pharmacie Centrale, Mulhouse, France Hôpital E Muller, Mulhouse, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Fizesan
authors.affiliation: Pharmacie Centrale, Mulhouse, France Hôpital E Muller, Mulhouse, France.
authors.forename: Christopher
authors.initials: C
authors.lastname: Boin
authors.affiliation: Pharmacie Centrale, Mulhouse, France Hôpital E Muller, Mulhouse, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Aujoulat
authors.affiliation: Hôpital E Muller, Mulhouse, France Service de Pneumologie et Allergologie, Mulhouse, France.
authors.forename: Georges
authors.initials: G
authors.lastname: Newinger
authors.affiliation: Hôpital E Muller, Mulhouse, France Service d'Hématologie Clinique et Unité de Thérapie Cellulaire, Mulhouse, France.
authors.forename: Dana
authors.initials: D
authors.lastname: Ghergus
authors.affiliation: CNRS UMR 7292, Université François-Rabelais, CHRU de Tours, Tours, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Watier
authors.affiliation: Pharmacie Centrale, Mulhouse, France Hôpital E Muller, Mulhouse, France.
authors.forename: Hélène
authors.initials: H
authors.lastname: Lustig
authors.affiliation: Hôpital E Muller, Mulhouse, France Service d'Hématologie Clinique et Unité de Thérapie Cellulaire, Mulhouse, France ojedam@ch-mulhouse.fr.
authors.forename: Mario
authors.initials: M
authors.lastname: Ojeda-Uribe
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D000079963:Brentuximab Vedotin; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D006689:Hodgkin Disease / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D018796:Immunoconjugates / Q000276:immunology*; D017730:Ki-1 Antigen / Q000276:immunology; D008297:Male; D011241:Prednisone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D018796:Immunoconjugates; D017730:Ki-1 Antigen; D001761:Bleomycin; D011344:Procarbazine; D014750:Vincristine; D005047:Etoposide; D000079963:Brentuximab Vedotin; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone